Abstract: The present invention relates to disubstituted piperidinyl renin inhibitor compounds having the structure (Formula I) and their use in treating cardiovascular events and renal insufficiency.
Type:
Grant
Filed:
November 14, 2007
Date of Patent:
December 13, 2011
Assignee:
Merck Canada Inc.
Inventors:
Daniel Dube, Michel Gallant, Erich L. Grimm, Helene Juteau, Sebastien Laliberte, Tom Yao-Hsiang Wu